CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-03 | Thomas Joe Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-10-03 | Thomas Joe Director | Grant or award · Stock Option (Right to Buy) | +48,207 | $0.99 | $47K | 48,207 |
| 2017-10-31 | Thomas Joe Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 3 trades